Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...
Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...
Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a $257 million Series D financing co--led by investment funds managed by BlackRock and Eclipse, ...
The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...
The FDA granted orphan drug designation to CTD402 for relapsed or refractory T-cell acute lymphoblastic leukemia and ...
Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results